Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is liver cancer?
The liver is a large organ under the right ribs that filters the blood, makes proteins, and helps digest food. Most primary liver cancer is hepatocellular carcinoma (HCC), which usually arises in a liver already scarred by long-standing hepatitis B or C, heavy alcohol use, or fatty liver disease. Because the liver works quietly, tumors can grow without symptoms, so people at risk benefit from regular ultrasound screening. Caught small, liver cancer can frequently be cured; even when surgery isn't possible, focused radiation and other liver-directed treatments can control it for years.
The main types
Doctors group liver cancer by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Hepatocellular carcinoma (HCC) | By far the most common type — it starts in the main liver cells (hepatocytes) and is closely tied to underlying liver damage (cirrhosis). |
| Intrahepatic cholangiocarcinoma | A cancer of the small bile ducts inside the liver; less common and treated somewhat differently from HCC. |
| Metastatic (secondary) liver tumors | Cancer that spread to the liver from elsewhere (such as colon cancer). This is more common than primary liver cancer and is treated based on the original cancer. |
Staging, in plain terms
Liver cancer uses both the standard TNM system (tumor size, lymph nodes, spread) and a special liver-focused system called BCLC (Barcelona Clinic Liver Cancer). BCLC matters because it combines the tumor with how well the liver itself is working and how a patient feels — all of which guide treatment.
| BCLC | What it generally means |
|---|---|
| Very early / Early (BCLC 0-A) | A single small tumor (or a few small ones) in a reasonably healthy liver. Often curable with surgery, ablation, or focused radiation/transplant. |
| Intermediate (BCLC B) | Larger or multiple tumors still confined to the liver. Treated with liver-directed therapies such as bead/chemoembolization or radiation. |
| Advanced (BCLC C) | Cancer has invaded blood vessels or spread beyond the liver. Treated mainly with modern systemic medicines, sometimes with targeted radiation. |
| End-stage (BCLC D) | The liver is failing and the focus shifts to comfort and quality of life. |
The standard of care
Liver Cancer is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Surgery & transplant
Removing the tumor, or replacing the whole liver with a transplant, offers the best chance of cure for early cancer in patients who qualify.
Ablation & embolization
Heat (radiofrequency/microwave) destroys small tumors; chemo- or radioembolization delivers treatment straight into the tumor's blood supply through a catheter.
Radiation therapy
Stereotactic body radiation (SBRT) precisely destroys tumors that can't be removed, and is an increasingly used bridge to transplant or a stand-alone cure for small cancers.
Systemic medicine
Immunotherapy combinations and targeted drugs are now first-line for advanced HCC and can shrink tumors and extend life significantly.
How radiation treatment works
Radiation uses focused high-energy x-rays to break the DNA inside cancer cells so they can no longer divide and die off. The liver is sensitive, so modern stereotactic radiation uses breath-control and on-board imaging to lock onto a tumor that moves as you breathe, concentrating the dose on the cancer while protecting healthy liver tissue. Treatments are painless and brief — usually a handful of sessions over one to two weeks. Most people feel well; some notice temporary fatigue or mild nausea that settles afterward.
The main ways radiation is delivered for liver cancer:
Stereotactic body radiation therapy (SBRT)
Delivers a few precise high-dose treatments to a liver tumor while sparing the healthy liver around it. It is an effective option when surgery and ablation aren't feasible, and controls most small tumors.
Selective internal radiation (radioembolization)
Tiny radioactive beads are threaded through a catheter into the artery feeding the tumor, lodging there and irradiating the cancer from the inside while sparing the rest of the body.
Palliative external-beam radiation
Eases pain or bleeding when cancer has grown large or spread, using gentle, targeted treatments to relieve symptoms.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
SBRT for inoperable liver cancer: Stereotactic radiation controls the large majority of small HCC tumors and is now a recognized option for patients who can't have surgery or ablation, including as a bridge to transplant.[1]
Multi-institution HCC SBRT series, 2023-2025
Immunotherapy transforms advanced HCC: The combination of atezolizumab plus bevacizumab improved survival over older targeted therapy and reset the first-line standard for advanced liver cancer.[2]
IMbrave150 trial, NEJM
Radiation plus systemic therapy: Emerging trials combine liver-directed radiation with immunotherapy to treat tumors that have invaded blood vessels, an area of active progress.[3]
Recent combined-modality HCC trials
Common questions
Can liver cancer be cured? Yes — when it's found early as a single small tumor in a reasonably healthy liver, surgery, transplant, ablation, or focused radiation can cure it. Screening people at risk is the key to finding it that early.
Why do I need radiation if I have cirrhosis? Surgery may be too risky in a scarred liver, but stereotactic radiation can destroy a tumor without an operation and while protecting the remaining liver, making it a valuable option.
Who should be screened for liver cancer? People with cirrhosis or chronic hepatitis B or C benefit from a liver ultrasound (often with a blood test) about every six months, because early tumors are the ones that can be cured.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.